A Review of the Pharmaceutical Industry of Canada

Three important aspects of the Canadian pharmaceutical industry-viz. compulsory licence, price control on patented drugs and the R&D scenario. Unlike other developed countries, which have adopted the route of providing higher Intellectual Property Rights (IPR) protection to promote the growth of the domestic pharmaceutical industry, Canada chose to limit the IPRs on important pharmaceutical products. Though the pharmaceutical industry of India and Canada share a few common points of comparison, the most important point of divergence between Canada and India is that while the Indian pharmaceutical industry is supported by a well-established homegrown fine chemical industry, Canada lacks this advantage. [Working Paper No. 151].